Sign Up Today and Learn More About Calibrate Stock
Invest in or calculate the value of your shares in Calibrate or other pre-IPO companies through EquityZen's platform.
Calibrate Stock (CALB)
Calibrate is a digital metabolic health business that is changing the way the world treats weight.
About Calibrate Stock
Founded
2020
Headquarters
New York, NY, US
Industries
Software, Artificial Intelligence, Data and Analytics
Calibrate is a digital metabolic health business that provides a virtual program for weight loss. It is creating a new category by improving metabolic health to drive long-term, sustainable weight loss with a program designed by world leaders in obesity and nutrition science. Calibrate combines FDA-approved metabolic medication with a holistic curriculum and 1:1 virtual coaching sessions that drive lasting behavior change. The company was founded in 2020 and is headquartered in New York.
Calibrate Press Mentions
Stay in the know about the latest news on Calibrate
Pearl Launches Calibrate, Dentistryâs First AI-Powered Clinical Calibration Tool
businesswire ⢠Oct 29, 2024
Metabolic health startup Calibrate names new CEO as it eyes expansion in employer, payer market
fiercehealthcare ⢠Feb 18, 2024
Weight loss startup Calibrate raises $29M as part of private equity restructuring
endpts ⢠Nov 02, 2023
Exclusive: CEO of Ozempic prescription startup Calibrate steps down as investors eye ârapid down-sizingâ of consumer business
fortune ⢠Oct 31, 2023
Weight Loss Startup Calibrate Is Changing Hands
medcitynews ⢠Oct 24, 2023
Calibrate Management
Leadership team at Calibrate
Founder, CEO
Isabelle Kenyon
Chief Medical Officer
Kim Boyd
Join now and verify your accreditation status to gain access to:
- Calibrate current valuation
- Calibrate stock price
- Available deals in Calibrate and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Calibrate Stock
How to invest in Calibrate stock?
Accredited investors can buy pre-IPO stock in companies like Calibrate through EquityZen funds. These investments are made available by existing Calibrate shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event â house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Calibrate stock?
Shareholders can sell their Calibrate stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
